ASTH · XBRL financial data
Astrana Health financial statements, every quarter
The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters (ASTH's year ends in late December)
| In millions of dollars | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from contracts with customers | 348 | 353* | 404 | 486 | 479 | 665* | 620 | 655 | 956 | 951* | 965 | 973 |
| General and administrative | 29 | 38* | 39 | 36 | 38 | 42* | 44 | 51 | 62 | 60* | 62 | 54 |
| Operating income (loss) | 39 | (4)* | 30 | 30 | 28 | 1* | 21 | 20 | 19 | 18* | 29 | 34 |
| Interest income | 3 | 5* | 4 | 4 | 4 | 3* | 2 | 2 | 4 | 4* | 4 | 6 |
| Interest expense | 4 | 5* | 8 | 9 | 9 | 8* | 7 | 7 | 18 | 18* | 16 | 16 |
| Other income (expense) | 2 | 2* | (4) | 6 | 3 | 0* | (5) | 1 | 0 | 1* | 1 | (2) |
| Income tax expense (benefit) | 10 | 1* | 7 | 10 | 8 | 6* | 3 | 7 | 5 | 1* | 7 | 9 |
| Net income (loss) | 22 | 12* | 15 | 19 | 16 | (7)* | 7 | 9 | 0 | 6* | 14 | 20 |
| Earnings per share, basic USD per share | 0.47 | 0.26* | 0.31 | 0.40 | 0.34 | (0.15)* | 0.14 | 0.19 | 0.01 | 0.12* | 0.30 | 0.40 |
| Earnings per share, diluted USD per share | 0.47 | 0.26* | 0.31 | 0.40 | 0.33 | (0.14)* | 0.14 | 0.19 | 0.01 | 0.12* | 0.29 | 0.40 |
| Weighted average shares, basic millions of shares | 47 | 47* | 47 | 48 | 48 | 48* | 48 | 49 | 49 | 49* | 49 | 49 |
| Weighted average shares, diluted millions of shares | 47 | 47* | 48 | 48 | 48 | 48* | 49 | 49 | 49 | 50* | 49 | 50 |
Balance sheet
CSVFiscal quarters (ASTH's year ends in late December)
| In millions of dollars | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | 274 | 294 | 335 | 325 | 348 | 288 | 259 | 340 | 462 | 429 | 478 | 401 |
| Marketable securities | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | — | — | — |
| Accounts receivable | — | — | — | — | — | 276 | — | 349 | 381 | 374 | 467 | 465 |
| Prepaid and other current assets | 14 | 17 | 17 | 17 | 21 | 23 | 24 | 22 | 23 | 26 | 26 | 26 |
| Total current assets | 476 | 462 | 539 | 570 | 597 | 638 | 613 | 729 | 884 | 863 | 1,004 | 919 |
| Property and equipment, net | — | — | — | — | — | 14 | — | — | — | 57 | 60 | 63 |
| Right-of-use asset | 21 | 37 | 39 | 29 | 33 | 33 | 31 | 31 | 34 | 36 | 34 | 39 |
| Goodwill | 276 | 279 | 410 | 410 | 410 | 419 | 416 | 417 | 863 | 865 | 875 | 887 |
| Total assets | 1,073 | 933 | 1,226 | 1,252 | 1,285 | 1,355 | 1,331 | 1,442 | 2,237 | 2,219 | 2,359 | 2,282 |
| Current portion of long-term debt | 3 | 20 | 21 | 17 | 15 | 9 | 13 | 13 | 48 | 48 | 48 | 54 |
| Total current liabilities | 203 | 219 | 355 | 310 | 313 | 366 | 361 | 460 | 630 | 615 | 745 | 748 |
| Long-term debt | 206 | 259 | 368 | 425 | 423 | 425 | 404 | 401 | 1,002 | 991 | 980 | 883 |
| Lease liability, non-current | 21 | 36 | 38 | 27 | 31 | 31 | 29 | 29 | 30 | 32 | 30 | 34 |
| Total liabilities | 458 | 523 | 774 | 774 | 778 | 841 | 814 | 904 | 1,682 | 1,660 | 1,781 | 1,684 |
| Retained earnings | 231 | 243 | 258 | 277 | 293 | 286 | 293 | 302 | 302 | 308 | 323 | 342 |
| Total stockholders' equity | 594 | 614 | 653 | 679 | 705 | 713 | 745 | 765 | 776 | 779 | 800 | 830 |
| Total liabilities and equity | 1,073 | 933 | 1,226 | 1,252 | 1,285 | 1,355 | 1,331 | 1,442 | 2,237 | 2,219 | 2,359 | 2,282 |
| Common shares outstanding (cover page) millions of shares | 58 | 55 | 56 | 56 | 56 | 56 | 56 | 56 | 56 | 56 | 56 | 56 |
Cash flows
CSVFiscal quarters (ASTH's year ends in late December)
| In millions of dollars | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | 22 | 12* | 15 | 19 | 16 | (7)* | 7 | 9 | 0 | 6* | 14 | 20 |
| Stock-based compensation | 6* | 9* | 6 | 7* | 6* | 15* | 8 | 12* | 8* | 11* | 10 | 12* |
| Depreciation and amortization | 4* | 5* | 5 | 7* | 7* | 8* | 7 | 7* | 16* | 16* | 15 | 16* |
| Net cash from operating activities | 15* | 19* | 6 | 23* | 34* | (11)* | 17 | 91* | 10* | (3)* | 68 | 33* |
| Purchases of property and equipment | 4* | 7* | 0 | 3* | 2* | 3* | 3 | 1* | 3* | 3* | 4 | 4* |
| Net cash from investing activities | (35)* | (11)* | (71) | (80)* | (8)* | (33)* | (2) | (1)* | (534)* | (1)* | (3) | (6)* |
| Proceeds from issuing common stock | — | year only | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | 0* | 1* | — | — | 0* | 1* | 11 | 0* | 0* | 15* | 3 | 0* |
| Dividends paid | 1* | 60* | 0 | 2* | 0* | 2* | 5 | 1* | 0* | 2* | 0 | 0* |
| Repayments of long-term debt | 0* | — | — | — | — | — | — | — | — | — | — | — |
| Net cash from financing activities | (1)* | 12* | 106 | 47* | (3)* | (15)* | (44) | (9)* | 648* | (26)* | (16) | (104)* |
| Net change in cash | (20)* | 20* | 41 | (9)* | 23* | (60)* | (30) | 81* | 124* | (30)* | 49 | (78)* |
Compare with peers
SIC 8742 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 8742 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Astrana Health | 401 | 973 | 33* | 55.7M | — | 10-QJun 30, 2026 |
| Evolent Health | 116 | 653 | (9.3)* | 113.1M | 12.4 quarters | 10-QJun 30, 2026 |
| ICF International | 4.6 | 474 | 100* | 17.9M | — | 10-QJun 30, 2026 |
| Onterris | 13 | 187 | 6.2* | 35.1M | — | 10-QJun 30, 2026 |
| V2X | 265 | 1,271 | 67* | 31.4M | — | 10-QOct 2, 2026 |
| Premier | 43 | 240 | 16 | 82.7M | — | 10-QSep 30, 2025 |
| TSS | 68 | 35 | 7.6* | 28.2M | — | 10-Q/AJun 30, 2026 |
| Huron Consulting Group | 26 | 491 | 57* | 15.8M | — | 10-QSep 30, 2026 |
| Hackett Group | 14 | 69 | 15* | 24.9M | — | 10-QJun 26, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.